- Home
- INLF vs PHIO Comparison
INLF vs PHIO Comparison
Compare INLF & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INLF
- PHIO
- Stock Information
- Founded
- INLF 2016
- PHIO 2011
- Country
- INLF China
- PHIO United States
- Employees
- INLF N/A
- PHIO N/A
- Industry
- INLF Industrial Machinery/Components
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- INLF Industrials
- PHIO Health Care
- Exchange
- INLF Nasdaq
- PHIO Nasdaq
- Market Cap
- INLF 10.9M
- PHIO 12.8M
- IPO Year
- INLF 2025
- PHIO N/A
- Fundamental
- Price
- INLF $0.60
- PHIO $1.18
- Analyst Decision
- INLF
- PHIO Strong Buy
- Analyst Count
- INLF 0
- PHIO 3
- Target Price
- INLF N/A
- PHIO $10.67
- AVG Volume (30 Days)
- INLF 76.9K
- PHIO 8.8M
- Earning Date
- INLF 09-29-2025
- PHIO 11-13-2025
- Dividend Yield
- INLF N/A
- PHIO N/A
- EPS Growth
- INLF N/A
- PHIO N/A
- EPS
- INLF N/A
- PHIO N/A
- Revenue
- INLF $19,332,282.00
- PHIO N/A
- Revenue This Year
- INLF N/A
- PHIO N/A
- Revenue Next Year
- INLF N/A
- PHIO N/A
- P/E Ratio
- INLF N/A
- PHIO N/A
- Revenue Growth
- INLF 33.11
- PHIO N/A
- 52 Week Low
- INLF $0.55
- PHIO $0.97
- 52 Week High
- INLF $21.00
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- INLF 25.34
- PHIO 24.02
- Support Level
- INLF $0.55
- PHIO $1.08
- Resistance Level
- INLF $0.70
- PHIO $1.32
- Average True Range (ATR)
- INLF 0.04
- PHIO 0.14
- MACD
- INLF -0.01
- PHIO -0.03
- Stochastic Oscillator
- INLF 19.54
- PHIO 16.05
About INLF INLIF LIMITED
INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.